Related Experiment Video
Updated: Jun 6, 2026
07:09
The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
Alpha-2 agonists as pain therapy in horses
1Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, 50 Stone Road, ON, Canada N1G 2W1. valverde@uoguelph.ca
The Veterinary Clinics of North America. Equine Practice
|November 9, 2010
Summary
Alpha-2 agonists offer potent analgesia but can cause side effects. Newer agents like medetomidine and dexmedetomidine show promise for equine anesthesia and analgesia, with potential for broader applications.
Area of Science:
- Veterinary Pharmacology
- Equine Medicine
Background:
- Alpha-2 agonists are effective analgesics with known side effects.
- Traditional alpha-2 agonists include xylazine, clonidine, romifidine, and detomidine.
- Physiologic changes like hypertension and bradycardia can limit their use.
Purpose of the Study:
- To review the use and potential benefits of alpha-2 agonists in equine anesthesia and analgesia.
- To explore newer agents like medetomidine and dexmedetomidine for equine applications.
- To examine potential advantages of alpha-2 agonists based on human and laboratory animal research.
Main Methods:
- Literature review of alpha-2 agonists in veterinary and human medicine.
- Analysis of pharmacologic properties and clinical effects.
- Evaluation of potential applications in equine patients.
Main Results:
- Medetomidine and dexmedetomidine offer increased alpha-2 receptor specificity.
- These newer agents may provide advantages over traditional alpha-2 agonists.
- Other routes of administration and benefits are documented in human and lab animal studies.
Conclusions:
- Medetomidine and dexmedetomidine show potential for equine anesthesia/analgesia.
- Further validation is needed for novel routes and benefits in horses.
- Alpha-2 agonists remain important for pain management in veterinary medicine.
Related Concept Videos
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:30Adrenergic Agonists: Therapeutic Uses
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
01:18Adrenergic Agonists: Therapeutic Classification
Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
01:30Adrenergic Agonists: Direct-Acting Agents
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...